Covered recipient · General Payments record
BRIAN FARRELL
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2018–2023
$1,500.06
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $317.53 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $84.51 | 4 |
| Smith & Nephew, Inc. | $60.59 | 2 |
| Medtronic, Inc. | $57.98 | 1 |
| GENZYME CORPORATION | $37.60 | 1 |
| Regeneron Healthcare Solutions, Inc. | $31.28 | 1 |
| OptiNose US, Inc. | $29.76 | 2 |
| Merck Sharp & Dohme Corporation | $15.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GENZYME CORPORATION | $37.60 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049631009 | CMS |
| GlaxoSmithKline, LLC. | $22.94 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002292189 | CMS |
| GlaxoSmithKline, LLC. | $18.66 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002289517 | CMS |
| GlaxoSmithKline, LLC. | $19.47 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002292268 | CMS |
| GlaxoSmithKline, LLC. | $23.44 | 12/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002289469 | CMS |
| Medtronic, Inc. | $57.98 | 11/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025943141 | CMS |
| Merck Sharp & Dohme LLC | $15.81 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048565627 | CMS |
| Optinose US, Inc. | $15.11 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1035130623 | CMS |
| Optinose US, Inc. | $14.65 | 11/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1035130877 | CMS |
| Regeneron Healthcare Solutions, Inc. | $31.28 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999168311 | CMS |
| Smith+Nephew, Inc. | $37.62 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053425875 | CMS |
| Smith+Nephew, Inc. | $22.97 | 09/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053425869 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.